AR245732A1 - Un procedimiento para la preparacion de agentes hipotensivos polipeptidos que contienen nor-estatina y nor-cicloestatina. - Google Patents
Un procedimiento para la preparacion de agentes hipotensivos polipeptidos que contienen nor-estatina y nor-cicloestatina.Info
- Publication number
- AR245732A1 AR245732A1 AR87309154A AR30915487A AR245732A1 AR 245732 A1 AR245732 A1 AR 245732A1 AR 87309154 A AR87309154 A AR 87309154A AR 30915487 A AR30915487 A AR 30915487A AR 245732 A1 AR245732 A1 AR 245732A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- amino
- ilox
- carbonil
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/14—Angiotensins: Related peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/205—Radicals derived from carbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
- C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0227—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
UN PROCEDIMIENTO PARA LA PREPARACION DE UN COMPUESTO DE FORMULA (I) Y (II), DONDE Z ES, R1-(Y)M-(A)P, T-(CH3)3COCONH, TIOMORFO-LINO-CARBONIL-AMINO SUFOXIDO, TIOMORFO-LINO-CARBONIL-AMINO SULFONA O 4-OXO-PIPERIDINO-CARBONIL- AMINO-ETILEN-CETAL,DONDE R1 ES ENTRE OTROS ALQUILO,AMINO,ALCOXI,ALQUIL AMINO,AMINO,CARBOXIALQUILO,HIDROXIALQUILEN-AMINO,ALCOXI- COCH2N(CH3),MORFOLINO,P IPERIDILO,HIDROXIPIPERIDINO,4- OXOPIPERIDINO,TIOMORFOLINO,N-ALCOXI-CARBONIL-PIPE RIDILO, 3,5- DIOXOMORFOLINO,HIDROXIPIRIDILO,(S)-PIRROLID-2-ILO,2-ALCOXI CARBONIL- PIRROLID-1-ILO O 4-ALCANOIL(C1-4)PIPERAZINO;Y ES C=O,P(OCH3)=O O SO2;A ES NH O NCH3;M Y P SON CADA UNO EL NRO.0 O 1;M ES FENILO,NAFTILO,TIENILO,METOXIFENILO O CLOROFENILO;Q ES METILO O HIDROGENO;R2 ES ENTRE OTROS ALQUILO,ALQUIL TIOALQUILO,ALCOXI- ALQQUILO,ALQUIL-SULFINILALQUILO,ALQUILSULFONILALQUILO,IMIDAZO L-4-IL- METILO,N-T-BUTOXICARBONIL-IMIDAZOL-4-IL-METILO O CARBAMILALQUILO;X ES CICLOHEXILO O ISOPROPILO;W ES CH-OCOALQUIL(C1-3)PIPERIDINO,CH-OH,C=O,CH- NH3,C H-OCOALQUILEN-CO2H;Z1 ES CH2OH CONHOCH3 O CONHCH2C(CH3)2CH2N(CH3)2,O R-U-T DONDE R ES C=O,U ES O,NH,N(CH3),CH2 O UN ENLACE QUIMICO ENTRE R Y T;T ES ALQUILO,HIDROXIALQUILO,CONH-ALQUILO,HIDROGENO,TRIFLUORETILO,CICLOALQUIL METILO,FENILO,BENCILO,AMINOALQUILO, U OMEGA-DIALQUIL AMINOALQUILO;L ES CH O N;R5 ES IMIDAZOL-4-IL-METILO O ALQUILO;Y R6 ES ALCOXI CON LAS CONDICIONES DEQUE CUANDO M ES 0,P ES 0;CUANDO T ES CONH-ALQUILO,U ES NH,N(CH3) O CH2;Y CUANDO T ES ALQUIL AMINO,U ES CH2 O UN ENLACE QUIMICO ENTRE R Y T;DONDE SE FORMA UNA UNION AMIDICA C(O)N,POR ACILACION DEL GRUPO ALFA-AMINO DESPROTEGIDO DE UN RESIDUO DE AMINO ACIDO CON UN AMINO ACIDO,UTILIZANDO UN REACTIVO COPULANTE,Y DONDE LOS GRUPOS FUNCIONALES NO IMPLICADOS EN LA REACCION PUEDEN ESTAR BLOQUEADOS
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92544986A | 1986-10-31 | 1986-10-31 | |
US6898287A | 1987-07-01 | 1987-07-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR245732A1 true AR245732A1 (es) | 1994-02-28 |
Family
ID=26749566
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AR87309154A AR245732A1 (es) | 1986-10-31 | 1987-10-29 | Un procedimiento para la preparacion de agentes hipotensivos polipeptidos que contienen nor-estatina y nor-cicloestatina. |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP0266950B1 (es) |
JP (1) | JPH07108901B2 (es) |
KR (1) | KR910002544B1 (es) |
CN (1) | CN1027271C (es) |
AR (1) | AR245732A1 (es) |
AU (1) | AU585180B2 (es) |
CA (1) | CA1310793C (es) |
DE (1) | DE3788626T2 (es) |
DK (1) | DK568487A (es) |
EG (1) | EG18378A (es) |
ES (1) | ES2061512T3 (es) |
FI (1) | FI90346C (es) |
HU (1) | HU207869B (es) |
IE (1) | IE61087B1 (es) |
IL (1) | IL84270A0 (es) |
MY (1) | MY103189A (es) |
NO (1) | NO173017C (es) |
NZ (1) | NZ222373A (es) |
PH (1) | PH25231A (es) |
PL (1) | PL151679B1 (es) |
PT (1) | PT86024B (es) |
YU (1) | YU46819B (es) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5214129A (en) * | 1985-01-23 | 1993-05-25 | Abbott Laboratories | Peptidylaminodiols |
IL81234A (en) * | 1986-01-16 | 1992-09-06 | Abbott Lab | Peptidylaminodiols,process for their preparation and pharmaceutical compositions comprising them |
WO1988003022A1 (en) * | 1986-10-31 | 1988-05-05 | Pfizer Inc. | Relatively low molecular weight polypeptides as renin inhibitors |
US4977141A (en) * | 1987-10-01 | 1990-12-11 | G. D. Searle & Co. | Peptidyl α-aminoacyl aminodiol carbamates as anti-hypertensive agents |
US4927807A (en) * | 1987-10-06 | 1990-05-22 | Abbott Laboratories | Glaucoma treatment |
JPH02503440A (ja) * | 1988-03-03 | 1990-10-18 | イー・アール・スクイブ・アンド・サンズ・インコーポレイテッド | 1,2‐ヒドロキシホスホネートおよびその誘導体 |
US5217958A (en) * | 1988-03-03 | 1993-06-08 | E. R. Squibb & Sons, Inc. | 1,2-hydroxy phosphonates and derivatives thereof |
US5736520A (en) * | 1988-10-07 | 1998-04-07 | Merrell Pharmaceuticals Inc. | Peptidase inhibitors |
ZA897514B (en) * | 1988-10-07 | 1990-06-27 | Merrell Dow Pharma | Novel peptidase inhibitors |
EP0376040A3 (en) * | 1988-12-27 | 1990-09-12 | American Cyanamid Company | N-phosphinyl di-and tripeptides as renin inhibitors |
US4965372A (en) * | 1989-01-19 | 1990-10-23 | Pfizer Inc. | Process and intermediates for isopropyl 3S-amino-2R-hydroxy-alkanoates |
WO1990009172A1 (en) * | 1989-02-16 | 1990-08-23 | Pfizer Inc. | Phosphorus containing renin inhibitors |
US5468732A (en) * | 1989-02-16 | 1995-11-21 | Pfizer Inc. | Phosphorus containing renin inhibitors |
US5216013A (en) * | 1989-12-04 | 1993-06-01 | G. D. Searle & Co. | Aralkyl-N-terminal cycloalkoxy-C terminal amino hydroxy β-amino acid derivatives |
US5231111A (en) * | 1989-12-04 | 1993-07-27 | G. D. Searle & Co. | Imidazolyl/imidazolylalkyl-N-terminal cycloalkoxy-C-terminal amino hydroxy β-amino acid derivatives |
US5180744A (en) * | 1989-12-04 | 1993-01-19 | G. D. Searle & Co. | Aralkyl-N-terminal amino hydroxy |
US5212175A (en) * | 1989-12-04 | 1993-05-18 | G. D. Searle & Co. | Benzothiophenyl benzothiophenylalkyl-N-terminal amino hydroxy β-amino acid derivatives |
US5215996A (en) * | 1989-12-04 | 1993-06-01 | G. D. Searle & Co. | Naphthyridinyl/naphthyridinylalkyl-N-terminal cycloalkoxy-C-terminal amino hydroxy β-amino acid derivatives |
US5217991A (en) * | 1989-12-04 | 1993-06-08 | G. D. Searle & Co. | Cycloalkyl/cycloalkylalkyl-N-terminal cycloalkoxy-C-terminal amino hydroxy β-amino acid derivatives |
US5217988A (en) * | 1989-12-04 | 1993-06-08 | G. D. Searle & Co. | Indolyl indolylakyl-N-terminal cycloalkoxy-C-terminal amino hydroxyβ-amino acid derivatives |
US5223532A (en) * | 1989-12-04 | 1993-06-29 | G. D. Searle & Co. | Chromonyl/chromonylalkyl-N-terminal cycloalkoxy-C-terminal amino hydroxy β-amino derivatives |
US5223514A (en) * | 1989-12-04 | 1993-06-29 | G. D. Searle & Co. | Quinolinyl/quinolinylalkyl-N-terminal cycloalkoxy-C-terminal amino hydroxy β-amino acid derivatives |
US5223512A (en) * | 1989-12-04 | 1993-06-29 | G. D. Searle & Co. | Quinolonyl/quinolonylalkyl-N-terminal cycloalkoxy-C-terminal amino hydroxy β-amino acid derivatives |
US5180725A (en) * | 1989-12-04 | 1993-01-19 | G. D. Searle & Co. | Quinoxalinyl/quinoxaliy; alkyl-N-terminal amino hydroxy |
US5175170A (en) * | 1989-12-04 | 1992-12-29 | G. D. Searle & Co. | β-amino acid derivatives |
US5223534A (en) * | 1989-12-04 | 1993-06-29 | G. D. Searle & Co. | Benzofuuranyl/benofuranylaklyl-N-terminal cycloalkoxy-C-terminal amino hydroxy β-amino acid derivatives |
US5179102A (en) * | 1989-12-04 | 1993-01-12 | G. D. Searle & Co. | Naphthyridinyl/naphthyridinylalkyl-n-terminal anino hydroxy β-amino acid derivatives |
IE66574B1 (en) * | 1989-12-04 | 1996-01-24 | Searle & Co | Heterocyclic acyl aminodiol beta-amino acid derivatives |
US5147888A (en) * | 1989-12-04 | 1992-09-15 | G. D. Searle & Co. | N-terminal indolyy indolylalkylaminodiol β-amino acid derivatives |
US5171751A (en) * | 1989-12-04 | 1992-12-15 | G. D. Searle & Co. | Benzofuran/benzofuranalkyl-N-terminal amino hydroxy |
US5175181A (en) * | 1989-12-04 | 1992-12-29 | G. D. Searle & Co. | Imidazolyl/imidazolylalkyl-N-terminal amino hydroxy |
US5210095A (en) * | 1989-12-04 | 1993-05-11 | G. D. Searle & Co. | Chromonyl/chromonylalkyl-N-terminal amino hydroxy |
US5217989A (en) * | 1989-12-04 | 1993-06-08 | G. D. Searle & Co. | Benothiophenyl/benzothiophenylalkyl-N-terminal cycloalkoxy-C-terminal amino hydroxy β-amino acid derivatives |
TW209870B (es) * | 1990-01-18 | 1993-07-21 | Pfizer | |
US5023338A (en) * | 1990-03-08 | 1991-06-11 | American Home Products Corporation | Renin inhibitors |
US5075451A (en) * | 1990-03-08 | 1991-12-24 | American Home Products Corporation | Pyrrolimidazolones useful as renin inhibitors |
US5064965A (en) * | 1990-03-08 | 1991-11-12 | American Home Products Corporation | Renin inhibitors |
US5095119A (en) * | 1990-03-08 | 1992-03-10 | American Home Products Corporation | Renin inhibitors |
US5278161A (en) * | 1990-06-28 | 1994-01-11 | Hoffmann-La Roche Inc. | Amino acid derivatives useful as renin inhibitors |
JPH04243835A (ja) * | 1990-08-29 | 1992-08-31 | Pfizer Inc | 高眼圧症又は緑内障治療用薬剤組成物及び治療方法 |
US5442105A (en) * | 1991-06-21 | 1995-08-15 | Takasago International Corporation | Process for producing cyclohexylbutyric acid derivative |
JP2847584B2 (ja) * | 1991-06-21 | 1999-01-20 | 高砂香料工業株式会社 | シクロヘキシル酪酸誘導体及びその製造法 |
WO1993011799A1 (en) * | 1991-12-18 | 1993-06-24 | Pfizer Inc. | Soybean protein or hydrolyzates in pharmaceutical compositions to protect bioactive peptides from enzymatic inactivation |
US6153592A (en) * | 1992-11-09 | 2000-11-28 | Port Systems, Llc | Enhancing the bioavailability of proteolytically labile therapeutic agents |
US5872101A (en) * | 1995-01-06 | 1999-02-16 | Sibia Neurosciences, Inc. | Methods of treating neurodegenerative disorders using protease inhibitors |
US5804560A (en) * | 1995-01-06 | 1998-09-08 | Sibia Neurosciences, Inc. | Peptide and peptide analog protease inhibitors |
US6107329A (en) * | 1995-06-06 | 2000-08-22 | Pfizer, Inc. | Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors |
WO2000026191A1 (fr) | 1998-11-04 | 2000-05-11 | Meiji Seika Kaisha, Ltd. | Derives de picolinamide et pesticides contenant ces derives comme ingredient actif |
US6117870A (en) * | 1998-11-12 | 2000-09-12 | Fujirebio Kabushiki Kaisha | Cyclic amide derivatives |
US20020002152A1 (en) | 2000-04-14 | 2002-01-03 | Craig Richard A. | Hydrazide and alkoxyamide angiogenesis inhibitors |
UA108742C2 (uk) | 2009-09-23 | 2015-06-10 | Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1254699A (en) * | 1984-03-12 | 1989-05-23 | Jasjit S. Bindra | Renin inhibitors containing statine or derivatives thereof |
DE3418491A1 (de) * | 1984-05-18 | 1985-11-21 | Merck Patent Gmbh, 6100 Darmstadt | Diaminosaeurederivate |
EP0190891A3 (en) * | 1985-01-31 | 1988-04-20 | Kissei Pharmaceutical Co. Ltd. | Novel amino acid derivatives |
US4743585A (en) * | 1986-11-21 | 1988-05-10 | Warner-Lambert Company | Renin inhibitors |
NZ222755A (en) * | 1986-12-23 | 1989-11-28 | Warner Lambert Co | Renin inhibiting acyl peptide derivatives containing two to four amino acid residues, and pharmaceutical compositions |
-
1987
- 1987-10-19 MY MYPI87002941A patent/MY103189A/en unknown
- 1987-10-25 IL IL84270A patent/IL84270A0/xx unknown
- 1987-10-27 EP EP87309461A patent/EP0266950B1/en not_active Expired - Lifetime
- 1987-10-27 DE DE87309461T patent/DE3788626T2/de not_active Expired - Fee Related
- 1987-10-27 ES ES87309461T patent/ES2061512T3/es not_active Expired - Lifetime
- 1987-10-28 CA CA000550413A patent/CA1310793C/en not_active Expired - Fee Related
- 1987-10-29 PT PT86024A patent/PT86024B/pt unknown
- 1987-10-29 EG EG620/87A patent/EG18378A/xx active
- 1987-10-29 AR AR87309154A patent/AR245732A1/es active
- 1987-10-30 NZ NZ222373A patent/NZ222373A/xx unknown
- 1987-10-30 YU YU198087A patent/YU46819B/sh unknown
- 1987-10-30 IE IE292987A patent/IE61087B1/en not_active IP Right Cessation
- 1987-10-30 AU AU80541/87A patent/AU585180B2/en not_active Ceased
- 1987-10-30 HU HU874901A patent/HU207869B/hu not_active IP Right Cessation
- 1987-10-30 NO NO874530A patent/NO173017C/no unknown
- 1987-10-30 KR KR1019870012079A patent/KR910002544B1/ko not_active IP Right Cessation
- 1987-10-30 FI FI874787A patent/FI90346C/fi not_active IP Right Cessation
- 1987-10-30 DK DK568487A patent/DK568487A/da not_active Application Discontinuation
- 1987-10-30 PL PL1987268521A patent/PL151679B1/pl unknown
- 1987-10-30 CN CN87101499A patent/CN1027271C/zh not_active Expired - Fee Related
-
1988
- 1988-06-23 PH PH37109A patent/PH25231A/en unknown
-
1994
- 1994-09-16 JP JP6221930A patent/JPH07108901B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR245732A1 (es) | Un procedimiento para la preparacion de agentes hipotensivos polipeptidos que contienen nor-estatina y nor-cicloestatina. | |
IT8748495A0 (it) | Composizione di collirio isotonico umettante | |
BR1100989A (pt) | Composto e composição de matéria | |
NL971014I1 (nl) | Heterocyclische verbindingen. | |
ES2092345T3 (es) | Compuestos organicos de silicio que contienen radicales glicosido, y procesos para su preparacion. | |
AR241018A2 (es) | "n-(ciclopropil-triazinil-y-pirimidinil)-n'- (bencensulfonil) ureas con accion herbicida, procedimiento para su preparacion, intermediarios y composiciones que las contienen" | |
ATE131863T1 (de) | Verwendung von halogenkohlenwasserstofflösungsmittel als reinigungsmittel | |
FI852974A0 (fi) | Nya n-hydroxylgruppen skyddande grupper och framstaellningsfoerfarande foer 3-acylamino-1-hydroxi-2-azetidinoner. | |
AR246265A1 (es) | Acidos imidoperxocarboxilicos, procedimientos para su preparacion y su utilizacion. | |
ES2054826T3 (es) | Peptidos con actividad inhibidora de colagenasa. | |
DE3561741D1 (de) | Triphenedioxazine vinylsulfonyl dyestuffs | |
AR246512A1 (es) | Procedimiento para la produccion de 2,2,6,6-tetraalquil-4-piperidilaminas. | |
CA1266675C (es) | ||
PT83725A (de) | Verzweigte alkyl-beta-carboline | |
ES2062805T3 (es) | Procedimiento para la preparacion de sulfatos ciclicos. | |
KR850000755B1 (en) | Process for preparing 3,1-benzoxazin-2-ones and acid addition salts thereof | |
AR247397A1 (es) | Compuestos de 1-oxa-3-oxo-4,8-diaza-espiro ¡4,5¿ decano. | |
ATE78830T1 (de) | Lactamderivate, deren herstellung und deren benutzung als hypotensive mittel. | |
ATE40370T1 (de) | Phenylengruppen-haltige organosilane, verfahren zu ihrer herstellung. | |
ATE126212T1 (de) | Ureidoperoxicarbonsäuren, verfahren zu deren herstellung und deren verwendung. | |
DE3381243D1 (de) | Aminopyrimidinone als histamin-h2-antagonisten. | |
ES2059374T3 (es) | Substancia 4181-2 y sus derivados. | |
SE8303913D0 (sv) | Heterocykliska foreningar | |
ATE14876T1 (de) | Diisocyanate. | |
NO891609D0 (no) | Anti-hypertensive sulfonanilider. |